| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.51 | 0.06 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.43 | 0.007 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.38 | 0.01 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.35 | 0.02 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.32 | 0.02 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.29 | 2e-07 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.29 | 0.09 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.26 | 4e-06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.26 | 2e-05 |